Most want abortion pill to remain available — CBS News poll
Many women feel access to reproductive health care is getting harder, not easier.
Watch CBS News
Many women feel access to reproductive health care is getting harder, not easier.
Mifepristone is still widely available, but that could change this week.
Limits on how late into a pregnancy the drug can be taken, who can prescribe it and how it can be dispensed were set to take effect Saturday at 1 a.m.
The Biden administration and a drug manufacturer have asked the Supreme Court to preserve access to an abortion drug, free of restrictions.
Attorney General Merrick Garland said in a statement the Justice Department "strongly disagrees" with the decision from an appeals court.
The court maintained access to mifepristone for the time being but is only letting it be dispensed after a doctor's office visit, not by mail, and up to seven weeks into a pregnancy, not 10.
The abortion pill mifepristone is due to be pulled off pharmacy shelves by Friday, setting up a potential legal fight that could go all the way to the Supreme Court.
The rulings set up a potential legal fight that could go all the way to the Supreme Court, CBS2's Alice Gainer reports.
Some Republicans urge their party to proceed cautiously when it comes to the issue. CBS2's Cristian Benavides has the latest.
Xavier Becerra, President Biden's health secretary, did not rule out defying a Texas judge's order if necessary.
One federal judge stripped the drug's FDA approval, but another said it should remain available.
The abortion medication pill can still be accessed right now. We won't know for another week if that will change.
The FDA approved mifepristone more than 20 years ago.
However, another judge issued a very different ruling on the same drug, CBS2's Christina Fan reports.
A federal judge in Texas on Friday halted the Food and Drug Administration's approval of the abortion pill mifepristone. CBS News senior investigative correspondent Catherine Herridge was joined by CBS News legal contributor Jessica Levinson to examine the ruling.
A federal judge in Texas heard arguments Wednesday in a closely watched dispute that could halt distribution of a key drug used for medication abortion and disrupt access nationwide, even in states where reproductive rights are protected. CBS2's Dick Brennan reports.
The bill would allow the state to license free-standing birthing centers for low-risk pregnancies.
Medication abortion accounts for the majority of abortions in the U.S.
Among the mayor's planned initiatives, he wants to relaunch the Sexual Education Task Force.
Race takes on new intensity as Democratic governor and Republican challenger ramp up attacks.
The announcement came as Gov. Kathy Hochul and Republican challenger Lee Zeldin entered the homestretch in the New York gubernatorial race. CBS2's Marcia Kramer has the story.
The money will cover 64 clinic sites across New York as part of the Abortion Provider Support Fund.
Gov. Kathy Hochul and the state's health commissioner discuss access to reproductive care in New York.
Marcia Kramer discusses abortion rights and more with Republican Rep. Nicole Malliotakis and Democratic challenger Max Rose exclusively on CBS News New York.
School says overturning Roe v. Wade will "result in lower graduation rates and derail employment trajectories."
